(Reuters) -Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash, aiming to diversify from legacy products ...
Reflect Orbital, a Santa Monica-based space tech company, raised a $20-million Series A round to accelerate development of its satellite constellation designed to deliver sunlight on demand. The round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback